Randomized controlled trial of TDCS on cognition in 201 seniors with mild neurocognitive disorder.

At T2 and T3, ADAS‐Cog showed a trend for reverting toward the baseline, but the performance was still significantly better than baseline (T3: tDCS‐WMT group: P = 0.047, Cohen’d = −0.212; sham tDCS‐WMT group: P = 0.045, Cohen’d = −0.239; tDCS‐CCT group: P = 0.021, Cohen’d = −0.328).

also in 53,322 other papers